| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.13B | +19.2% |
| Cost of Revenue | $508.5M | +29.3% |
| Gross Profit | $2.62B | +17.4% |
| R&D Expense | $905.9M | +16.3% |
| SG&A Expense | $326.0M | +8.6% |
| Operating Income | $7.4M | +110.9% |
| Pre-tax Income | $69.5M | +142.2% |
| Income Tax | $23.6M | -2.1% |
| Net Income | $45.9M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $882.2M | +72.1% |
| Accounts Receivable | $419.1M | +25.2% |
| Current Assets | $2.45B | -7.0% |
| Total Assets | $3.85B | +1.5% |
| Current Liabilities | $1.47B | -6.7% |
| Total Liabilities | $1.79B | -5.3% |
| Stockholders' Equity | $2.07B | +8.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $760.7M | +27.1% |
| Capital Expenditures | $53.2M | +40.1% |
| Investing Cash Flow | $491.8M | +195.3% |
| Financing Cash Flow | -$910.0M | -1801.1% |
| Free Cash Flow | $707.6M | +26.2% |
| +892.0% |
| EPS (Basic) | $0.88 | +877.8% |
| EPS (Diluted) | $0.86 | +855.6% |